dalteparin has been researched along with Community Acquired Infection in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amezyane, T | 1 |
Abouzahir, A | 1 |
El Kharrass, A | 1 |
Bassou, D | 1 |
Fatihi, J | 1 |
Hammi, S | 1 |
Mahassin, F | 1 |
Ghafir, D | 1 |
Ohayon, V | 1 |
Dean, NC | 1 |
Bateman, KA | 1 |
Donnelly, SM | 1 |
Silver, MP | 1 |
Snow, GL | 1 |
Hale, D | 1 |
2 other studies available for dalteparin and Community Acquired Infection
Article | Year |
---|---|
[Septic pylephlebitis associated with Enterobacter cloacae septicemia].
Topics: Abdominal Pain; Adult; Anti-Bacterial Agents; Anticoagulants; Bacteremia; Ceftriaxone; Community-Acq | 2010 |
Improved clinical outcomes with utilization of a community-acquired pneumonia guideline.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anticoagulants; Azithromycin; Community-Acquired Inf | 2006 |